Live MD Anderson Cancer Center updates

Live MD Anderson Cancer Center news coverage of developments with the latest updates. Stay on top of latest MD Anderson Cancer Center news stories and find out what just happened, what is going on with MD Anderson Cancer Center. The latest real-time news updates and headlines on MD Anderson Cancer Center
City of Hope Researcher Leads Successful Phase 3 Trial for Hodgkin Lymphoma Treatment
Targeted Therapy Shows Promise for HER2-Amplified Biliary Tract Cancer
Targeted Therapy Induces Responses in HER2-Amplified Biliary Tract Cancer, ASCO Reports
Small-cell Lung Cancer Patients with SLFN11 Expression Benefit from PARP inhibitor with Immune Checkpoint Blockade: SWOG S1929 Results
Paclitaxel Worsens Frequent & Clinically Significant Breast Cancer-Related Neuropathy
No Benefit in Extensive Lymph Node Removal for Muscle-Invasive Bladder Cancer Patients
Pan-Cancer T Cell Atlas Unveils New Tumor Microenvironment Insights
Pan-Cancer T Cell Atlas Reveals New Details of Tumor Microenvironment
Imfinzi + Lynparza or Imfinzi Alone Improve Endometrial Cancer Survival
Luspatercept Enables Majority of Patients with MDS to End Reliance on Blood Transfusions, ASCO Reports
Mays Cancer Center Conducts Only US Clinical Trial of Drug Combo for Glioblastoma
Rice and Baylor team up to create glyco-immune checkpoint inhibitor
Breakthrough Cancer awards MD Anderson $5.7M for AML research
Engineered Virus and Immunotherapy Combo Safe, Improves Glioblastoma Outcomes
Engineered virus and immunotherapy combo safe and effective for glioblastoma patients
Xin Zhang Wins STAT Madness 2023 All-Star Award
MD Anderson’s Research Highlights May 10, 2023
Researchers Discover Standard for Gallbladder Cancer Surgery
Current and Future Approach to Systemic AL Amyloidosis
Breast Cancer Tumors Disrupt Immune System, Promote Own Growth
Gene Tiam1 Drives Onset of Chronic Neuropathic Pain
Potential Therapeutic Target for Neuropathic Pain Revealed in Mice
Breast Cancer Tumors Disrupt Immune System to Promote Growth
Gene Tiam1 Drives Development of Chronic Neuropathic Pain
Immunotherapy Redefines Cancer Treatment, Benefit Varies
Gut Microbes Modify Body’s Response to Cancer Immunotherapy
Gut Microbes May Enhance Cancer Immunotherapy
MD Anderson, Generate:Biomedicines Partner on Protein Therapeutics using AI
MD Anderson’s Kantarjian Wins Top Honor from American Society of Clinical Oncology
New Drug Combo Revives Blood Cancer Treatment’s Cell Death Signaling
Single-Cell Study Reveals Immunosuppressive Tumor Microenvironment in Brain Metastases from Kidney Cancer
Single-Cell Study Reveals Immunoregulation in Kidney Cancer Brain Metastases
FGFR and PARP/ATR Inhibitors Show Benefits in Multiple Tumor Types
FGFR Inhibitors & PARP/ATR Combinations Show Promise in Multiple Tumor Types: Early AACR Results
FGFR Inhibitors & PARP/ATR Combinations Show Promise in Multiple Tumor Types: Early AACR Results
IU Cancer Center Researcher Leads First In-Human Multiple Myeloma Study with 90.5% Response Rate
Mutations in 3 Genes Linked to Poor Lung Cancer Treatment Outcomes
Mutations in 3 Key Genes Linked to Poor Lung Cancer Outcomes with KRAS G12C Inhibitors
SWOG Reports Results in Gynecologic Cancer Immunotherapy Trial
Novel Allogeneic CAR T Therapy Shows Promise for Metastatic Renal Cell Carcinoma
Novel Allogeneic CAR T Therapy Shows Promise for Metastatic Renal Cell Carcinoma
YAP/TEAD Inhibitor VT3989 Shows Antitumor Activity in Mesothelioma and NF2-Mutant Cancers
High Response Rate to Pembrolizumab in Unresectable Desmoplastic Melanoma Trial
YAP/TEAD inhibitor VT3989 shows promise in mesothelioma & NF2-mutant cancers
Immunotherapy-Based Treatment Improves Lung Cancer Outcomes Pre- and Post-Surgery, Says AACR
Imfinzi reduces disease recurrence in lung cancer by 32% in Phase III trial
UC Irvine Researchers Identify Hallmarks for Improving Pancreatic Cancer Therapy
Combination therapy overcomes BET inhibitor resistance